Moxetumomab pasudotox-tdfk Intravenous and Supartz injection
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Supartz injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: sodium hyaluronate
Brand name: Durolane, Euflexxa, Gel-One, Gelsyn-3, Hyalgan, Supartz, Supartz FX, Visco-3, Trivisc, GenVisc 850, Monovisc, Orthovisc, Synvisc, Synvisc-One
Synonyms: Supartz (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Super Cold Tabs
- Moxetumomab pasudotox-tdfk Intravenous-Super Dent Topical Anesthetic Gel
- Moxetumomab pasudotox-tdfk Intravenous-Super Strength Sinadrin
- Moxetumomab pasudotox-tdfk Intravenous-SuperiorSource K1
- Moxetumomab pasudotox-tdfk Intravenous-Supervite
- Moxetumomab pasudotox-tdfk Intravenous-Suphedrin
- Supartz injection-Moxifloxacin
- Supartz injection-Moxifloxacin (Systemic)
- Supartz injection-Moxifloxacin Hydrochloride
- Supartz injection-Moxifloxacin Injection
- Supartz injection-Moxifloxacin Intravenous
- Supartz injection-Moxifloxacin Tablets